Yubo International Biotech Ltd Balance Sheet
YBGJ|11 years of annual SEC 10-K data (FY2011-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 11 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Total Assets
$847,094
FY2025
Cash
$8,062
Cash and equivalents
Total Debt
N/A
FY2025
Shareholder Equity
-$2M
FY2025
Yubo International Biotech Ltd had $847,094 in total assets with negative shareholders' equity of $2M as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -14.17 (distress zone, below 1.23 threshold)
- Negative shareholders equity: Liabilities exceed assets
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8.1K | $7.0K | $6.4K | $18.2K | $1.4M | $1.3K | $2.0K | $1.0K | $11.0K | $12.0K | $7.0K |
| Inventory | $24.0K | $37.0K | $214.6K | $322.2K | $67.1K | - | - | - | - | - | - |
| Current Assets | $667.5K | $682.8K | $725.2K | $750.0K | $1.9M | $4.0K | $5.0K | $4.0K | $14.0K | $15.0K | $10.0K |
| PP&E (Net) | $43.0K | $205.9K | $375.2K | $616.7K | $79.2K | - | - | - | - | - | - |
| Total Assets | $847.1K | $1.5M | $1.7M | $2.3M | $2.4M | $4.0K | - | - | - | - | - |
| Current Liabilities | $2.8M | $4.7M | $3.4M | $2.5M | $1.3M | $1.7M | $1.5M | $1.4M | $1.3M | $1.1M | $729.0K |
| Shareholders' Equity | -$2.0M | -$3.4M | -$1.8M | -$565.4K | $1.2M | $488.7K | -$1.5M | -$1.4M | -$1.3M | -$1.1M | -$719.0K |